Matches in SemOpenAlex for { <https://semopenalex.org/work/W2064558082> ?p ?o ?g. }
Showing items 1 to 75 of
75
with 100 items per page.
- W2064558082 abstract "Prostate cancer (PCa) is one of the most common cancers and the second leading cause of cancer-related death in western countries. In China, the incidence has increased, unexpectedly and sharply, for the past 20 years. Chemo-resistance, in various types of tumor including PCa, is one of the critical problems in cancer therapy. In PCa, for example, the resistance to taxanes (DTX) accounts for tumor relapse and progression resulting in skeletal metastasis and high mortality. Epithelial-mesenchymal transition (EMT) has been suggested as a key process that dominates chemo-resistance through unknown mechanisms. In the current study, we reported that CCL2 and interleukin-6 (IL-6) serve as key molecules in EMT-mediated chemo-resistance in PCa cells using previously established paclitaxel-resistant cells, DU145-TxR and PC-3-TxR. Parental DU145 and PC-3 cells were used as controls. We observed that DU145-TxR and PC-3-TxR cells produced significantly higher amount of CCL2 and IL-6 compared to their parental cells, determined by cytokine array. In addition, DU145-TxR and PC-3-TxR cells demonstrated EMT phenotypes including hall maker changes in E-cadherin and Vimentin expression and transcriptional factor (Snail, ZEB1, and Slug) alterations. These changes were reversed partially by adding neutralizing antibodies against either CCL2 or interleukin-6. Interestingly, synergistic effects were observed by adding both reagents. Finally DU145-TxR, PC-3-TxR, or their parental cells were implanted into SCID mice and the mice were given DTX (10mg/kg, biweekly) and tumor growth was monitored for 4 weeks. Both DU145-TxR and PC-3-TxR tumors grew faster than the parental tumors. Tumor tissues were collected and total RNAs were isolated. Levels of CCL2 expression in these tumors were significantly higher in DU145-TxR and PC-3-TxR tumors. IHC analysis confirmed corresponding staining of EMT markers such as E-cadherin and Vimentin expression. Together we concluded that CCL2 and IL-6 regulates EMT-mediated chemo-resistance in prostate cancer. These results are of high impact of human prostate cancer chemotherapy. Supported by U.S. Department of Defense PC061231 (J. Zhang), National Natural Sciences Foundation Key Project (81130046, J. Zhang) and National Natural Science Foundation Project (81171993, Y. Lu). Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research; 2012 Mar 31-Apr 4; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2012;72(8 Suppl):Abstract nr 841. doi:1538-7445.AM2012-841" @default.
- W2064558082 created "2016-06-24" @default.
- W2064558082 creator A5009344458 @default.
- W2064558082 creator A5016322661 @default.
- W2064558082 creator A5036460015 @default.
- W2064558082 creator A5056820426 @default.
- W2064558082 creator A5057209439 @default.
- W2064558082 creator A5087520734 @default.
- W2064558082 date "2012-04-15" @default.
- W2064558082 modified "2023-09-26" @default.
- W2064558082 title "Abstract 841: CCL2 and interleukin-6 regulate EMT-mediated chemo-resistance in prostate cancer" @default.
- W2064558082 doi "https://doi.org/10.1158/1538-7445.am2012-841" @default.
- W2064558082 hasPublicationYear "2012" @default.
- W2064558082 type Work @default.
- W2064558082 sameAs 2064558082 @default.
- W2064558082 citedByCount "1" @default.
- W2064558082 countsByYear W20645580822017 @default.
- W2064558082 crossrefType "proceedings-article" @default.
- W2064558082 hasAuthorship W2064558082A5009344458 @default.
- W2064558082 hasAuthorship W2064558082A5016322661 @default.
- W2064558082 hasAuthorship W2064558082A5036460015 @default.
- W2064558082 hasAuthorship W2064558082A5056820426 @default.
- W2064558082 hasAuthorship W2064558082A5057209439 @default.
- W2064558082 hasAuthorship W2064558082A5087520734 @default.
- W2064558082 hasConcept C121608353 @default.
- W2064558082 hasConcept C126322002 @default.
- W2064558082 hasConcept C203014093 @default.
- W2064558082 hasConcept C2776438761 @default.
- W2064558082 hasConcept C2778690821 @default.
- W2064558082 hasConcept C2779013556 @default.
- W2064558082 hasConcept C2779723316 @default.
- W2064558082 hasConcept C2780192828 @default.
- W2064558082 hasConcept C502942594 @default.
- W2064558082 hasConcept C71924100 @default.
- W2064558082 hasConcept C86803240 @default.
- W2064558082 hasConcept C96232424 @default.
- W2064558082 hasConceptScore W2064558082C121608353 @default.
- W2064558082 hasConceptScore W2064558082C126322002 @default.
- W2064558082 hasConceptScore W2064558082C203014093 @default.
- W2064558082 hasConceptScore W2064558082C2776438761 @default.
- W2064558082 hasConceptScore W2064558082C2778690821 @default.
- W2064558082 hasConceptScore W2064558082C2779013556 @default.
- W2064558082 hasConceptScore W2064558082C2779723316 @default.
- W2064558082 hasConceptScore W2064558082C2780192828 @default.
- W2064558082 hasConceptScore W2064558082C502942594 @default.
- W2064558082 hasConceptScore W2064558082C71924100 @default.
- W2064558082 hasConceptScore W2064558082C86803240 @default.
- W2064558082 hasConceptScore W2064558082C96232424 @default.
- W2064558082 hasLocation W20645580821 @default.
- W2064558082 hasOpenAccess W2064558082 @default.
- W2064558082 hasPrimaryLocation W20645580821 @default.
- W2064558082 hasRelatedWork W1497362436 @default.
- W2064558082 hasRelatedWork W1597484389 @default.
- W2064558082 hasRelatedWork W1966315017 @default.
- W2064558082 hasRelatedWork W1966763146 @default.
- W2064558082 hasRelatedWork W1971779373 @default.
- W2064558082 hasRelatedWork W2003025781 @default.
- W2064558082 hasRelatedWork W2063235168 @default.
- W2064558082 hasRelatedWork W2069997827 @default.
- W2064558082 hasRelatedWork W2112995806 @default.
- W2064558082 hasRelatedWork W2285097862 @default.
- W2064558082 hasRelatedWork W2314808245 @default.
- W2064558082 hasRelatedWork W2321163358 @default.
- W2064558082 hasRelatedWork W2326857721 @default.
- W2064558082 hasRelatedWork W2401385852 @default.
- W2064558082 hasRelatedWork W2491592048 @default.
- W2064558082 hasRelatedWork W2556619639 @default.
- W2064558082 hasRelatedWork W2565108650 @default.
- W2064558082 hasRelatedWork W2734945380 @default.
- W2064558082 hasRelatedWork W2740057824 @default.
- W2064558082 hasRelatedWork W3013923618 @default.
- W2064558082 isParatext "false" @default.
- W2064558082 isRetracted "false" @default.
- W2064558082 magId "2064558082" @default.
- W2064558082 workType "article" @default.